Phio Pharmaceuticals Corp.

PHIO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.01

-$0.02 (-1.94%)

At close: Sep 21, 2026, 4:00 PM ET

$1.06

+$0.05 (+4.95%)

Pre-market: Sep 22, 2026, 5:37 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	1K	1.48M	1.18M	1.07M	15K	985K	644K	866K	1.15M	43K	1.81M	49K	2.13M	1.61M	2.51M	1.3M	1.59M	2.23M	2.67M	n/a	2.43M
Gross Profit	n/a	-1K	-1.48M	-1.18M	-1.07M	-15K	-985K	-644K	-866K	-1.15M	-43K	-1.81M	-49K	-2.13M	-1.61M	-2.51M	-1.3M	-1.59M	-2.23M	-2.67M	n/a	-2.43M
Operating Income	n/a	-4.17M	-2.53M	-2.51M	-2.31M	-1.87M	-1.67M	-1.59M	-1.91M	-2.21M	-1.77M	-2.78M	-2.55M	-3.6M	-2.73M	-3.57M	-2.52M	-2.64M	-3.45M	-3.74M	-2.68M	-3.64M
Interest Income	n/a	161K	n/a	n/a	119K	125K	231K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-4.14M	-4M	-2.37M	-2.39M	-2.17M	-1.77M	-1.63M	-1.52M	-1.85M	-2.15M	-1.9M	-2.78M	-2.55M	-3.6M	-2.73M	-3.58M	-2.53M	-2.64M	-3.45M	-3.74M	-2.69M	-3.41M
Net Income	-4.14M	-4M	-2.37M	-2.39M	-2.17M	-1.77M	-1.63M	-1.52M	-1.85M	-2.15M	-1.9M	-2.78M	-2.55M	-3.6M	-2.73M	-3.58M	-2.53M	-2.64M	-3.45M	-3.74M	-2.69M	-3.41M
Selling & General & Admin	1.19M	1.37M	1.06M	1.32M	1.24M	986K	689K	946K	1.05M	1.06M	723K	968K	1.16M	1.47M	1.12M	1.06M	1.22M	1.05M	1.23M	1.07M	1.13M	1.21M
Research & Development	3.08M	2.79M	1.48M	1.18M	1.07M	886K	985K	644K	866K	1.15M	1.01M	1.81M	1.38M	2.13M	1.61M	2.51M	1.3M	1.59M	2.23M	2.67M	1.56M	2.43M
Other Expenses	n/a	n/a	-1.48M	-1.18M	-1.07M	-15K	-985K	-644K	-866K	-1.15M	n/a	-1.81M	-49K	-2.13M	-1.61M	-2.51M	-1.3M	-1.59M	-2.23M	-2.67M	n/a	-2.43M
Operating Expenses	4.27M	4.17M	1.06M	1.32M	1.24M	1.86M	689K	946K	1.05M	1.06M	1.73M	968K	2.5M	1.47M	1.12M	1.06M	1.22M	1.05M	1.23M	1.07M	2.68M	1.21M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5K	10K	2K	1K	3K	3K	2K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	4.17M	2.53M	2.51M	2.31M	1.87M	1.67M	1.59M	1.91M	2.21M	1.77M	2.78M	2.55M	3.6M	2.73M	3.57M	2.52M	2.64M	3.45M	3.74M	2.68M	3.64M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	11.62M	11.62M	11.62M	5.47M	4.79M	4.31M	787.47K	990.03K	510.19K	508.39K	415.95K	270.86K	191.86K	126.79K	126.43K	126.38K	126.34K	125.47K	125.19K	125.19K	125.19K	98.79K
Shares Outstanding (Diluted)	11.62M	11.62M	11.62M	5.47M	4.79M	4.31M	787.47K	990.03K	510.19K	508.39K	415.95K	270.86K	191.86K	126.79K	126.43K	126.38K	126.34K	125.47K	125.19K	125.19K	125.19K	98.79K
EPS (Basic)	-0.36	-0.34	-0.20	-0.44	-0.45	-41.07K	-0.37	-1.54	-3.62	-4.24	-4.56	-10.26	-13.29	-28.41	-20.52	-28.33	-20.11	-21.07	-27.57	-29.89	-21.46	-34.49
EPS (Diluted)	-0.36	-0.34	-0.20	-0.44	-0.45	-41.07K	-0.37	-1.54	-3.62	-4.24	-4.56	-10.26	-13.29	-28.41	-20.52	-28.33	-20.11	-21.07	-27.57	-29.89	-21.46	-34.49
EBITDA	n/a	-4M	-2.37M	-2.39M	-2.17M	-1.77M	-1.58M	-1.52M	-1.85M	-2.12M	-1.85M	-2.77M	-2.53M	-3.59M	-2.72M	-3.56M	-2.5M	-2.62M	-3.43M	-3.72M	-2.67M	-3.62M
EBIT	n/a	-4M	-2.37M	-2.39M	-2.17M	-1.77M	-1.63M	-1.52M	-1.85M	-2.15M	-1.9M	-2.78M	-2.55M	-3.6M	-2.73M	-3.57M	-2.52M	-2.64M	-3.45M	-3.74M	-2.68M	-3.64M
Depreciation & Amortization	n/a	1K	1K	2K	500	n/a	42K	n/a	1K	34K	43K	15K	15K	16K	15K	15K	19K	22K	20K	19K	18K	18K